The ability of a nomogram that included RPL4P4 expression, age, IDH mutation status, primary therapy outcome, 1p19q codeletion, and WHO grade to accurately predict prognosis in glioma patients was tested. The gene discussed is RPL4P4; the disease is central nervous system cancer.